Tag | Content |
---|
EnhancerAtlas ID | HS139-39238 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr3:170223750-170225780 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Crx | MA0467.1 | chr3:170224274-170224285 | TTAATCCTCTT | - | 6.14 | EWSR1-FLI1 | MA0149.1 | chr3:170225004-170225022 | ATTTCCTTCCTTTATTCC | - | 6.36 | NFE2L1 | MA0089.2 | chr3:170224517-170224532 | TCTGCTGAGTCACTT | - | 6.49 | SPI1 | MA0080.4 | chr3:170225041-170225055 | GAAATGAGGAAGTG | + | 6.22 | TFAP4 | MA0691.1 | chr3:170225137-170225147 | AACAGCTGAT | + | 6.02 |
|
| Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
SE_04916 | chr3:170223640-170225681 | Brain_Cingulate_Gyrus | SE_06833 | chr3:170223708-170225167 | Brain_Hippocampus_Middle_150 | SE_07973 | chr3:170223634-170225572 | Brain_Inferior_Temporal_Lobe | SE_33527 | chr3:170223688-170225570 | H2171 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH03I170506 | chr3 | 170224389 | 170224789 |
|
Enhancer Sequence | TGAGTTACCT TTCTAATCAT ATTTGCCTTA TGCTATTATC GAAGTGATTT TACATTTTGT 60 GGTTATCCAC CAAGTGATTA GAGGGAGAGG CATATTGATT TCAAAAGTAC TTATTGATAT 120 AGCTAGAGAG AATCAATATG AAATCCAGTG TTTAGGTGCA GGCAGCCATC AGTGAGTGAC 180 TGCATGCTGC AGACCACATG ATGGAAATTT TCCCTTAGTG TTGGTCAGAG ATGAGAATTC 240 TAAGTCCTTG AGAAATATAA AGGATTTATT TCAGCAGGAC TAGAGGTAAT AAGCCTGCAA 300 GTCTGACACC TTTTCAATTA CCCACGATAT AAATCTATTG TAAACAGATT CCTATTTATA 360 TTTTGTCCCA TTTCTAGTGT TTTATATTTC TATACCCAGA ACTATTTGTG GTTAAATTGA 420 TAATTTGCCA GCCTAAAAAT CAGTTAGAAC TTGGAGTGAA CTTCCACATT GAAAAGTGGG 480 TTGGGACAAG GTACCGGGAG ATTCTCGATT TGCAATATTC TCTGTTAATC CTCTTATATG 540 TATCCCAGAT GATGTGTGAT TTGGGTTTTC AGAAAAATAT GGTCCTTTTC AATGTGAATT 600 TCTTTTCAAG TTACAGTCTA TGGTTCTATC ATATATGTAA ATAAAGAGCC AGCCTTAGGT 660 TTAGTTCTTT CAGACAGCCT ACATGCAATG TTGACCTTTC TAAACTATGC TTAACAGAGC 720 ACAACCCAAT AGCAAAGATA ATCACGACAT GCTTCTCCCT CTCTAATTCT GCTGAGTCAC 780 TTGCAGCCTA CCCGGATTCC CTATTGCCCT TTTAGAACCA GGAAGCAAAA CTTCTCCTTC 840 CTAACAGGGT AAAGGAGAAA GACCCAGCTG GGAGTAGGCA AAAGGAGGAA AATTCTATTT 900 TTAAGTGGGG AAGCTTTTCC ACTTAAGGGG TAAGTTATTG GGGGTACAGT TTATATAATA 960 TGATGAATTC AATTATTATG TTGCCTGATC ATAAGTGGAG AAAGGCTTCT CCACTTAAGA 1020 CATAAATTTC CCTCTGCATT CCACCAAAGA AAGCCATTAG ATAAATAAGT ACTTTTAAAT 1080 AAGTGTACTT TCACCTGGAA GGATTAAATC TAGGGGTTAT TCACACTTGA ATGCCAATTA 1140 CTCTACCCAG ATAGACAGAT TTTCCCATTA ATATGTAACT TATCTTACTT TGACTATTCC 1200 CTAACCTACT TATCAGCTCA TTTAACAGTT TCCCAAATAA TTTTTGACTT TCTAATTTCC 1260 TTCCTTTATT CCACACACAT TAAGTGGCTA TGAAATGAGG AAGTGCAATG AATGACAGAG 1320 ACACAAATGG TAAGACAGAT TTCCTGACCT TGAAGCATCT ATATTTCAAT CAGGAAAGAG 1380 TTTAATAAAC AGCTGATTCC ATGTGGCCAG TATTTAATAC TATTGAGCAT TTATGAGGTG 1440 TTCTTGGAGC TCAGTGCGGT GAGCGTGGTT CTTAGGAGCA CGGTTCTTTG GTTGCTGTGG 1500 AAGCCCGGAG ACTGGGGGAG GGAGCCTTTT AAGCTACTTC TTGGAGGGTA AGCTGGGCTT 1560 TGCCAGTCAG AAAAAAAATA GAGGAAAGGG TGGTTTCAGG CAGGCGAAAA GGTGTAGCTG 1620 GGCAGACACA TGCAGGCTAC TTTCGAGATT GTGGAAGATG AGCCTGCAGA GGTGGACTGA 1680 GATCAAGTGA TTGAGGGGGT GGGACCTTTT TAACAGACGA GTGGACTAGC TGAAAAGGAC 1740 TGTACAGTTC ATCTACTTGT ATAGTTTAAA GCTCTCTCTT AGTTGTAGAA CTCTATTTTC 1800 CACACACAGT CTTATTTGAG AGCCCAATAC ATAAATAGGT AAAAGCAGGT GGCTCCGTTT 1860 GAAGGGTGGG AGAACCGAGG CTGGTCTGCT CAAGGTCTCC TTCATCCCAT ACTTCCCCAA 1920 AGCCCCTCAC CCTCCTCTGT GGACCCCCAG GGCTGTACTG AGCATGGGAA TGGGAAGAGG 1980 TGTCAGTTGC TCATCAGAGT TGTTCTTTTA TTTTATAGAT GATGCAACTG 2030
|